THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

GABELLI FUNDS LLC's Holding History (CIK: 0001081407)

Note: Option positions (PUT/CALL) are excluded.

Q2 2021
Shares 3,000,000 Value ($000) $2,857 Avg Close — Range —
Q1 2021
Shares 3,000,000 Value ($000) $3,067 Avg Close — Range —
Q4 2020
Shares 3,000,000 Value ($000) $2,835 Avg Close — Range —
Q3 2020
Shares 3,000,000 Value ($000) $2,648 Avg Close — Range —
Q2 2020
Shares 3,000,000 Value ($000) $2,915 Avg Close — Range —
Q1 2020
Shares 3,000,000 Value ($000) $2,927 Avg Close — Range —
Q4 2019
Shares 2,000,000 Value ($000) $2,055 Avg Close — Range —
Q3 2019
Shares 2,000,000 Value ($000) $1,851 Avg Close — Range —
Q2 2019
Shares 2,000,000 Value ($000) $1,735 Avg Close — Range —
Q1 2019
Shares 2,000,000 Value ($000) $1,937 Avg Close — Range —
Q4 2018
Shares 2,000,000 Value ($000) $2,058 Avg Close — Range —
Q3 2018
Shares 2,000,000 Value ($000) $2,356 Avg Close — Range —
Q2 2018
Shares 2,000,000 Value ($000) $1,982 Avg Close — Range —
Q1 2018
Shares 2,000,000 Value ($000) $2,024 Avg Close — Range —
Q4 2017
Shares 2,000,000 Value ($000) $2,184 Avg Close — Range —
Q3 2017
Shares 2,000,000 Value ($000) $2,449 Avg Close — Range —
Q2 2017
Shares 2,000,000 Value ($000) $2,699 Avg Close — Range —
Q1 2017
Shares 2,000,000 Value ($000) $2,523 Avg Close — Range —
Q4 2016
Shares 2,000,000 Value ($000) $2,274 Avg Close — Range —